2011至2015年荷兰非远处转移乳腺癌腋窝手术趋势:ACOSOG-Z0011与AMAROS时代的人群研究
该研究基于荷兰全国乳腺癌审计数据,评估cT1-4N0M0乳腺癌腋窝手术模式,并分析ACOSOG-Z0011和AMAROS试验对cT1-2N0M0前哨淋巴结阳性患者腋窝手术的影响。结果显示前哨淋巴结活检作为确定性腋窝分期从72%增至93%,完成腋窝淋巴结清扫从24%降至6%;cT1-2N0前哨淋巴结阳性患者中完成腋窝淋巴结清扫从75%降至17%。
要点
- cT1-4N0M0乳腺癌中前哨淋巴结活检作为确定性分期从72%升至93%。
- cT1-2N0前哨淋巴结阳性患者完成腋窝淋巴结清扫从75%降至17%。
- 早期诊断年份、低龄、全乳切除、浸润性小叶癌、高分级和非教学医院与更低省略清扫概率相关。
核心结论
- 荷兰cT1-4N0M0乳腺癌腋窝手术呈减少趋势,前哨淋巴结活检增加而完成腋窝淋巴结清扫减少。
- cT1-2N0前哨淋巴结阳性患者中完成腋窝淋巴结清扫明显下降,但腋窝手术模式仍存在变异。
研究设计与样本
- 基于荷兰全国乳腺癌审计数据的描述性分析,使用多因素逻辑回归识别与省略完成腋窝淋巴结清扫相关的因素。
主要发现
- 2011至2015年cT1-4N0M0乳腺癌患者中,前哨淋巴结活检作为确定性腋窝分期从72%增至93%(P < 0.001)。
- (完成)腋窝淋巴结清扫作为确定性腋窝分期从24%降至6%(P < 0.001)。
- cT1-2N0前哨淋巴结阳性患者中完成腋窝淋巴结清扫从75%降至17%(P < 0.001)。
- 较早诊断年份、较低年龄、原发全乳切除、浸润性小叶亚型、较高肿瘤分级和非教学医院治疗与省略完成腋窝淋巴结清扫概率较低相关(P < 0.001)。
临床怎么用
- 在符合条件的cT1-2N0前哨淋巴结阳性乳腺癌患者中可考虑省略完成腋窝淋巴结清扫。
- 临床决策需注意机构类型、年龄、手术方式、组织学亚型和分级等因素相关的实践差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate patterns of care in axillary surgery for Dutch clinical T1-4N0M0 (cT1-4N0M0) breast cancer patients and to assess the effect of the American College for Surgeons Oncology Group (ACOSOG)-Z0011 and After Mapping of the Axilla: Radiotherapy Or Surgery (AMAROS) trial on axillary surgery patterns in Dutch cT1-2N0M0 sentinel node positive breast cancer patients. BACKGROUND: Since publication of the ACOSOG-Z0011 and AMAROS trial, omitting a completion axillary lymph node dissection (cALND) in sentinel node positive breast cancer patients is proposed in selected patients. METHODS: Data were obtained from the nationwide Nationaal Borstkanker Overleg Nederland breast cancer audit. Descriptive analyses were used to demonstrate trends in axillary surgery. Multivariable logistic regression analyses were used to identify factors associated with the omission of cALND in cT1-2N0M0 sentinel node-positive breast cancer patients. RESULTS: Between 2011 and 2015 in cT1-4N0M0 breast cancer patients, the use of sentinel lymph node biopsy as definitive axillary staging increased from 72% to 93%, and (c)ALND as definitive axillary staging decreased from 24% to 6% (P < 0.001). The use of cALND decreased from 75% to 17% in cT1-2N0 sentinel node-positive patients (P < 0.001). Earlier year of diagnosis, lower age, primary mastectomy, invasive lobular subtype, increasing tumor grade, and treatment in a nonteaching hospital were associated with a lower probability of omitting cALND (P < 0.001). CONCLUSIONS: This study shows a trend towards less extensive axillary surgery in Dutch cT1-T4N0M0 breast cancer patients; illustrated by an overall increase of sentinel lymph node biopsy and decrease in cALND. Despite this trend, particularly noticed in cT1-2N0 sentinel node-positive patients after publication of the ACOSOG-Z0011 and AMAROS trial, variations in patterns of care in axillary surgery are still present.
引用
- Poodt IGM, Spronk PER, Vugts G, et al. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg. 2018. PMID: 28742702. doi:10.1097/SLA.0000000000002440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。